(February 11, 2020, 11:38 AM EST) -- SAN FRANCISCO — Monsanto Co. on Feb. 7 filed a brief in California appellate court contending that an $86,742,310 glyphosate cancer verdict against the company should be reversed because the claims are preempted by federal law, there is “no substantial evidence” to support the verdict and a new trial is needed due to “prejudicial attorney misconduct” (Alva Pilliod, et al. v. Monsanto Company, No. A158228, Calif. App., Dist. 1)....